LOS ANGELES, March 10, 2011 /PRNewswire/ — InstaCare Corp. (OTC
Bulletin Board:
ISCR), a leading provider of prescription drugs, home testing
products for the chronically ill, a leading fulfillment provider of
direct to patient diabetes programs, and a leading developer of
revolutionary patent pending cell phone centric e-health
products and technologies, announced today that it is ready to ship
its new pharmaceutical e-detailing Mobile Health Media
System, known as MD@Detail.
The Company is also in serious, high-level discussions with two
large pharmaceutical firms and a smart phone provider for strategic
partnerships whereby physicians would receive the iPad free of
charge in return for a subscription to the e-detailing media
service. This model is currently widely in use in the prescription
detailing market. InstaCare will be paid fees by the e-detailing
sponsor to distribute the e-detailing media content.
Keith Berman, Secretary and CFO of InstaCare commented, “We have
received inquiry from three large parties that already have a stake
in the $3 billion pharma e-detailing (advertising) marketplace. All
three of these companies have special needs and have determined
that to move to the head of the pack they will need to better
merchandise their messages. InstaCare’s MD@Detail is
immediately available and the Company expects to move quickly to
completed partnership agreements.”
About MD@Hand, MD@Work and MD@DetailInstaCare’s MD@
technologies allow physicians to gain access to and securely store
immediate and critical patient information on smart cell phones,
tablet and/or handheld computers and other hybrid mobile devices.
The Company believes that no other technology platform
provides a physician a suite of robust, secure internet based
Electronic Medical Records (EMR) applications, patient medical
history applications, and prop
‘/>”/>
